MRAI:NSD-Marpai Inc (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 1.26

Change

-0.09 (-6.67)%

Market Cap

USD 0.02B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company offers health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
ALHC Alignment Healthcare LLC

-0.53 (-3.46%)

USD 3.12B
CLOV Clover Health Investments Corp

-0.06 (-1.95%)

USD 1.81B

ETFs Containing MRAI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.29% 67% D+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.29% 67% D+ 88% B+
Trailing 12 Months  
Capital Gain 26.00% 33% F 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.00% 33% F 79% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -22.34% 33% F 13% F
Dividend Return -22.34% 33% F 13% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 88.55% 67% D+ 21% F
Risk Adjusted Return -25.22% 33% F 25% F
Market Capitalization 0.02B 33% F 18% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector